Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L J Montaner

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Trends in Immunology|April 5, 2001
Structured treatment interruptions to control HIV-1 and limit drug exposureL J Montaner
Research in Immunology|October 1, 1994
Understanding HIV1, cytokines and effective immunity: bridging the gap between cytokine regulation in vitro and in vivoL J Montaner
Research in Immunology|October 1, 1994
Th2-mediated HIV1 virostatic state: macrophage-specific regulation in vitroL J Montaner, S Gordon
Journal of Leukocyte Biology|September 14, 2000
Proinflammatory response and IL-12 expression in HIV-1 infectionX Ma, L J Montaner
Lancet (London, England)|August 27, 1994
Th2 cytokines in AIDSL J Montaner, S Gordon
Journal of Leukocyte Biology|May 20, 1999
Chemokine immunobiology in HIV-1 pathogenesisB Lee, L J Montaner
Science (New York, N.Y.)|January 27, 1995
TH2 downregulation of macrophage HIV-1 replicationL J Montaner, S Gordon
Cellular and Molecular Biology (Noisy-Le-Grand, France)|August 15, 2001
Role of interleukin-13 in innate and adaptive immunityJ O Brubaker, L J Montaner
Journal of Virology|November 1, 1996
Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptorG Herbein, L J Montaner, S Gordon
Clinical and Experimental Immunology|March 19, 2011
Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN)C Tomescu, S Abdulhaqq, L J Montaner
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Trends in Immunology|April 5, 2001
Structured treatment interruptions to control HIV-1 and limit drug exposureL J Montaner
Research in Immunology|October 1, 1994
Understanding HIV1, cytokines and effective immunity: bridging the gap between cytokine regulation in vitro and in vivoL J Montaner
Research in Immunology|October 1, 1994
Th2-mediated HIV1 virostatic state: macrophage-specific regulation in vitroL J Montaner, S Gordon
Journal of Leukocyte Biology|September 14, 2000
Proinflammatory response and IL-12 expression in HIV-1 infectionX Ma, L J Montaner
Lancet (London, England)|August 27, 1994
Th2 cytokines in AIDSL J Montaner, S Gordon
Journal of Leukocyte Biology|May 20, 1999
Chemokine immunobiology in HIV-1 pathogenesisB Lee, L J Montaner
Science (New York, N.Y.)|January 27, 1995
TH2 downregulation of macrophage HIV-1 replicationL J Montaner, S Gordon
Cellular and Molecular Biology (Noisy-Le-Grand, France)|August 15, 2001
Role of interleukin-13 in innate and adaptive immunityJ O Brubaker, L J Montaner
Journal of Virology|November 1, 1996
Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptorG Herbein, L J Montaner, S Gordon
Clinical and Experimental Immunology|March 19, 2011
Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN)C Tomescu, S Abdulhaqq, L J Montaner
Pageof 4